http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2461070-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1dfd39878009ed672c93ba0247ee666
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 1993-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e00b6d6d9399d1f2ca2e79e3e8187e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0115a7511f0c9242e0197360a005d507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71e06b0a5e77fa4add3230aecf00e5b
publicationDate 2007-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2461070-C
titleOfInvention Photochemotherapeutic method using precursors of protoporphyrin ix
abstract Medicaments for detecting and treating malignant and non-malignant tissue abnormalities and lesions of the skin; conjunctiva; respiratory, digestive and vaginal mucosa; endometrium and urothelium; and for ablating the endometrial tissue and treating body fluids containing suspended abnormal cells, and for treating cancers of the nervous system are prepared from 5-aminolevulinic acid or precursor therof and subsequently administered to the patient in an amount sufficient to induce syntheses fluorescence and/or photosensitizing concentrations or protoporphyrin IX in the abnormal cells, followed by exposure of the abnormal cells to light of photoactivating wavelengths.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9550073-B2
priorityDate 1992-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423570488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449147235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57220345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433298372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353436
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150009356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078961

Total number of triples: 47.